Compounds > amphetamine

amphetamine and pirenzepine

amphetamine has been researched along with pirenzepine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's4 (66.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rasmussen, K; Stockton, ME1
Carl, KL; Holloway, FA; Mechanic, JA; Wasielewski, JA1
Chung, YC; Dai, J; Ichikawa, J; Li, Z; Meltzer, HY1
Holloway, FA; Maynard, BT; Mechanic, JA1
Gozes, I; Malkoff, A; Rehavi, M; Weizman, A1
He, N; Jin, DZ; Mao, LM; Sturich, AW; Wang, JQ1

Other Studies

6 other study(ies) available for amphetamine and pirenzepine

ArticleYear
Olanzapine, a novel atypical antipsychotic, reverses d-amphetamine-induced inhibition of midbrain dopamine cells.
    Psychopharmacology, 1996, Volume: 124, Issue:1-2

    Topics: Amphetamine; Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Dopamine Agents; Electrophysiology; Male; Mesencephalon; Olanzapine; Pirenzepine; Rats; Rats, Sprague-Dawley

1996
Attenuation of the amphetamine discriminative cue in rats with the atypical antipsychotic olanzapine.
    Pharmacology, biochemistry, and behavior, 2002, Volume: 72, Issue:4

    Topics: Amphetamine; Animals; Antipsychotic Agents; Benzodiazepines; Central Nervous System Stimulants; Conditioning, Operant; Cues; Discrimination, Psychological; Dose-Response Relationship, Drug; Male; Olanzapine; Pirenzepine; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reinforcement Schedule

2002
Cholinergic modulation of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Brain research, 2002, Dec-20, Volume: 958, Issue:1

    Topics: Acetylcholine; Adrenergic Uptake Inhibitors; Amphetamine; Animals; Cognition Disorders; Dopamine; Male; Muscarinic Agonists; Muscarinic Antagonists; Neurons; Nucleus Accumbens; Oxotremorine; Parasympatholytics; Pirenzepine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Schizophrenia; Scopolamine

2002
Treatment with the atypical antipsychotic, olanzapine, prevents the expression of amphetamine-induced place conditioning in the rat.
    Progress in neuro-psychopharmacology & biological psychiatry, 2003, Volume: 27, Issue:1

    Topics: Amphetamine; Animals; Antipsychotic Agents; Avoidance Learning; Benzodiazepines; Central Nervous System Stimulants; Drug Interactions; Male; Olanzapine; Physical Conditioning, Animal; Pirenzepine; Rats; Rats, Sprague-Dawley; Substance-Related Disorders

2003
Decreased M1 muscarinic receptor density in rat amphetamine model of schizophrenia is normalized by clozapine, but not haloperidol.
    Journal of neural transmission (Vienna, Austria : 1996), 2008, Volume: 115, Issue:11

    Topics: Amphetamine; Animals; Antipsychotic Agents; Central Nervous System Stimulants; Clozapine; DNA Primers; Haloperidol; Male; Muscarinic Antagonists; Pirenzepine; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Schizophrenia; Schizophrenic Psychology

2008
Inhibition of basal and amphetamine-stimulated extracellular signal-regulated kinase (ERK) phosphorylation in the rat forebrain by muscarinic acetylcholine M4 receptors.
    Brain research, 2018, 06-01, Volume: 1688

    Topics: Amphetamine; Animals; Brain; Central Nervous System Stimulants; Corpus Striatum; Dopamine; Hippocampus; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscarinic Antagonists; Phosphorylation; Pirenzepine; Prefrontal Cortex; Rats, Wistar; Receptor, Muscarinic M1; Receptor, Muscarinic M4; Tropicamide

2018